Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: Associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition

被引:43
作者
Barber, Thomas M. [1 ]
Hazell, Matthew [2 ]
Christodoulides, Constantinos
Golding, Stephen J. [3 ]
Alvey, Christopher [3 ]
Burling, Keith [4 ]
Vidal-Puig, Antonio [4 ]
Groome, Nigel P. [2 ]
Wass, John A. H.
Franks, Stephen [5 ]
McCarthy, Mark I.
机构
[1] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs, Oxford OX3 7LJ, England
[2] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England
[3] John Radcliffe Hosp, Dept Radiol, Oxford OX3 9DU, England
[4] Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0QQ, England
[5] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England
基金
英国医学研究理事会;
关键词
D O I
10.1210/jc.2007-2759
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Insulin resistance, which associates with levels of retinol-binding protein 4 (RBP4) and adiponectin, is implicated in the development of polycystic ovary syndrome ( PCOS). Objective: The objective of the study was to explore the potential contribution of RBP4 and adiponectin in the etiology of PCOS and their relationships with specific fat depot measurements. Design: This was a cross-sectional study. Setting and Participants: Serum RBP4 and adiponectin levels were compared between 50 PCOS cases and 28 female controls (including 22 body mass index/fat mass-matched pairs) and correlated with specific fat depot ( including visceral) axial magnetic resonance imaging cross-sectional area measurements. All subjects were of U. K. British/ Irish origin. Main Outcome Measure(s): Serum levels of RBP4 ( automated immunonephelometric assay) and adiponectin [immunoassay: total and high molecular weight (HMW)]. Data are reported as geometric mean (SD, range) and optionally adjusted for fat mass and age. Results: Between the 50 PCOS cases and 28 controls, serum RBP4 levels were indistinguishable [39.0 mu g/ml (31.0, 49.0) vs. 41.6 mu g/ml (32.7, 52.9), respectively, unadjusted P = 0.24; adjusted P = 0.55]. Total ( and HMW) adiponectin levels were lower in PCOS cases [ total adiponectin 19.9 mu g/ml (14.2, 27.8) vs. 25.8 mu g/ml (17.7, 37.7), respectively, unadjusted P = 2.4 x 10(-3); adjusted P = 0.10]. For the paired-sample analyzes, there were no differences in RBP4 (P = 0.09), total adiponectin ( P = 0.06), HMW adiponectin ( P = 0.19), or HMW to total adiponectin ratio (P = 0.98). In PCOS cases, L4-visceral fat area was associated positively with RBP4 ( r(2) = 0.34, P = 0.01) and negatively with HMW to total adiponectin ratio (r(2) = -0.44, P = 1.3 x 10(-3)). Controls showed similar relationships. Conclusions: Although associated with visceral fat, serum RBP4 and adiponectin levels do not play important, fat-mass-independent primary roles in the development of PCOS.
引用
收藏
页码:2859 / 2865
页数:7
相关论文
共 42 条
[1]   PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J].
ADAMS, J ;
POLSON, DW ;
FRANKS, S .
BRITISH MEDICAL JOURNAL, 1986, 293 (6543) :355-359
[2]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[3]   Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: Association with subclinical inflammation [J].
Balagopal, Prabhakaran ;
Graham, Timothy E. ;
Kahn, Barbara B. ;
Altomare, Astride ;
Funanage, Vicky ;
George, Donald .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05) :1971-1974
[4]   Obesity and polycystic ovary syndrome [J].
Barber, T. M. ;
McCarthy, M. I. ;
Wass, J. A. H. ;
Franks, S. .
CLINICAL ENDOCRINOLOGY, 2006, 65 (02) :137-145
[5]   Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome [J].
Barber, Thomas M. ;
Wass, John A. H. ;
McCarthy, Mark I. ;
Franks, Stephen .
CLINICAL ENDOCRINOLOGY, 2007, 66 (04) :513-517
[6]   The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome [J].
Bik, Wojciech ;
Baranowska-Bik, Agnieszka ;
Wolinska-Witort, Ewa ;
Chmielowska, Magdalena ;
Martynska, Lidia ;
Baranowska, Boguslawa .
GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (06) :325-331
[7]   Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[8]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].
Fauser, BCJM ;
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
HUMAN REPRODUCTION, 2004, 19 (01) :41-47
[9]   Follicular dynamics in the polycystic ovary syndrome [J].
Franks, S ;
Mason, H ;
Willis, D .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 163 (1-2) :49-52
[10]   Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome [J].
Glintborg, Dorte ;
Frystyk, Jan ;
Hojlund, Kurt ;
Andersen, Kristian Kjaer ;
Henriksen, Jan Erik ;
Hermann, Anne Pernille ;
Hagen, Claus ;
Flyvbjerg, Allan ;
Andersen, Marianne .
CLINICAL ENDOCRINOLOGY, 2008, 68 (02) :165-174